VARENZIN-CA1- molidustat oral suspension United States - English - NLM (National Library of Medicine)

varenzin-ca1- molidustat oral suspension

elanco us inc. - molidustat sodium (unii: ci0ne7c96t) (molidustat - unii:9jh486cz13) - varenzin-ca1 should not be administered to cats with known hypersensitivity to molidustat or to any of the inactive ingredients. varenzin-ca1 should not be administered to cats that are pregnant, lactating, or intended for breeding. in an embryo-fetal-developmental toxicity study in rats, an increase incidence of ocular malformations such as flat eye rudiments and microphthalmia were observed at doses of 30 mg/kg bw per day. these effects may be due to an increase in oxygen availability, caused by molidustat-induced polycythemia. localized hypoxia is an important factor in normal eye development. developmental toxicity studies have not been conducted in cats. available animal data have shown excretion of other hif-ph inhibitors into milk. it is unknown whether molidustat is excreted into the milk of lactating cats.

POSILAC- sometribove suspension United States - English - NLM (National Library of Medicine)

posilac- sometribove suspension

elanco us inc. - sometribove (unii: pbk5eqg5cq) (sometribove - unii:pbk5eqg5cq) - to increase production of marketable milk in healthy lactating dairy cows. caution: federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.

ELANCO AF0602 PAYLEAN 20 RACTOPAMINE HYDROCHLORIDE PREMIX Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco af0602 paylean 20 ractopamine hydrochloride premix

elanco australasia pty ltd - ractopamine hydrochloride - oral powder, pre-mix - ractopamine hydrochloride ungrouped active 20.0 g/kg - nutrition & metabolism - pig grower | grower finisher pig | pig grower/finisher - improve feed efficiency | increased carcass leanness | increased dressing percentage | productivity improvements | improving feed efficiency | increasing rate of weight gain

QUAD DEWORMER- praziquantel, pyrantel pamoate, febantel tablet, chewable United States - English - NLM (National Library of Medicine)

quad dewormer- praziquantel, pyrantel pamoate, febantel tablet, chewable

elanco us inc. - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457), pyrantel pamoate (unii: 81bk194z5m) (pyrantel - unii:4qih0n49e7), febantel (unii: s75c401os1) (febantel - unii:s75c401os1) - quad dewormer (praziquantel/pyrantel pamoate/febantel) chewable tablets for dogs will remove the common tapeworms, dipylidium caninum and taenia pisiformis , remove common hookworms, ancylostoma caninum and uncinaria stenocephala , remove common roundworms, toxocara canis and toxascaris leonina , and remove whipworms, trichuris vulpis in dogs.

PROFENDER (2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4h-pyrazino- 2,1-aisoquinolin-4-one, emodepside solution
PROFENDER (2 United States - English - NLM (National Library of Medicine)

profender (2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4h-pyrazino- 2,1-aisoquinolin-4-one, emodepside solution profender (2

elanco us inc. - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457), emodepside (unii: yz647y5gc9) (emodepside - unii:yz647y5gc9) - profender topical solution is indicated for the treatment and control of hookworm infections caused by ancylostoma tubaeforme (adults, immature adults, and fourth stage larvae), roundworm infections caused by toxocara cati (adults and fourth stage larvae), and tapeworm infections caused by dipylidium caninum (adults) and taenia taeniaeformis (adults) in cats.

BEXACAT- bexagliflozin tablets tablet United States - English - NLM (National Library of Medicine)

bexacat- bexagliflozin tablets tablet

elanco us inc. - bexagliflozin (unii: ey00jf42fv) (bexagliflozin - unii:ey00jf42fv) - bexacat (bexagliflozin tablets) are flavored pentagonal, 10 mm, speckled white, brown, or tan biconvex with a characteristic odor. the empirical formula is c24h29clo7 and the molecular weight is 464.94 g/mol. the chemical name is (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol. the chemical structure of bexagliflozin is:

BAYTRIL- enrofloxacin injection, solution United States - English - NLM (National Library of Medicine)

baytril- enrofloxacin injection, solution

elanco us inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy: baytril 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis . cattle - multiple-day therapy: baytril 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: baytril 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. baytril 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs whe

ADVANTAGE MULTI FOR DOGS- imidacloprid, moxidectin solution United States - English - NLM (National Library of Medicine)

advantage multi for dogs- imidacloprid, moxidectin solution

elanco us inc. - imidacloprid (unii: 3bn7m937v8) (imidacloprid - unii:3bn7m937v8), moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9) - advantage multi for dogs is indicated for the prevention of heartworm disease caused by dirofilaria immitis and the treatment of dirofilaria immitis circulating microfilariae in heartworm-positive dogs. advantage multi for dogs kills adult fleas and is indicated for the treatment of flea infestations (ctenocephalides felis ). advantage multi for dogs is indicated for the treatment and control of sarcoptic mange caused by sarcoptes scabiei var. canis. advantage multi for dogs is also indicated for the treatment and control of the following intestinal parasites: intestinal parasite intestinal stage adult immature adult fourth stage larvae hookworm species ancylostoma caninum x x x uncinaria stenocephala x x x roundworm species toxocara canis x x toxascaris leonina x whipworm trichuris vulpis x do not administer this product orally. (see warnings.) do not use this product (containing 2.5 % moxidectin) on cats.

COMPUDOSE- estradiol implant United States - English - NLM (National Library of Medicine)

compudose- estradiol implant

elanco us inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - safety and effectiveness following reimplantation have not been evaluated. do not use in beef calves less than 2 months of age, dairy calves, and veal calves because effectiveness and safety have not been established. do not use in animals intended for subsequent breeding or in dairy cows. not for use in humans. keep out of reach of children.

INCREXXA 25- tulathromycin injection United States - English - NLM (National Library of Medicine)

increxxa 25- tulathromycin injection

elanco us inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine increxxa 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica, haemophilus parasuis, and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae, pasteurella multocida, and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - increxxa 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis . the use of increxxa 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.